Carcinogenesis and Carcinogens — MCQs
Gastric carcinoma is associated with all of the following EXCEPT:
What is a potential outcome of the integration of a viral genome into a host cell chromosome?
Sun damage causes malignant transformation of the skin by:
Field carcinogenesis theory is commonly seen in
Which of the following is not a tumor suppressor gene?
Radiation causes cell death by:
Which of the following is not considered an occupational cancer?
The strongest occupational risk factor for hematological carcinoma is
Which of the following is NOT a recognized cause of Urothelial Carcinomas?
In which type of lung carcinoma is the p53 mutation most commonly observed?
Carcinogenesis and Carcinogens Indian Medical PG Practice Questions and MCQs
Question 1: Gastric carcinoma is associated with all of the following EXCEPT:
- A. Over expression of C-met
- B. Inactivation of p53
- C. Over expression of C-erb
- D. Activation of RAS (Correct Answer)
Explanation: ***Activation of RAS*** - **RAS mutations** are relatively uncommon in gastric carcinoma compared to other gastrointestinal malignancies. While KRAS mutations can occur in approximately 10-15% of gastric cancers (particularly intestinal type), they are **far less frequent** than in **pancreatic adenocarcinoma** (~90%) or **colorectal carcinoma** (~40%). - In the context of gastric carcinoma, RAS pathway alterations are **not considered a major oncogenic driver** compared to the other molecular changes listed, making this the **LEAST characteristically associated** alteration. *Inactivation of p53* - **Inactivation of the p53 tumor suppressor gene** is one of the most frequent molecular events in gastric carcinoma, occurring in approximately **50-60% of cases**. - Loss of p53 function leads to genomic instability, uncontrolled cell proliferation, and resistance to apoptosis, contributing significantly to **tumorigenesis** and **poor prognosis**. *Over expression of C-met* - **Overexpression of C-MET**, a receptor tyrosine kinase for hepatocyte growth factor (HGF), is commonly observed in gastric carcinoma (30-40% of cases) and is strongly linked to **tumor growth**, **invasion**, and **metastasis**. - C-MET amplification and overexpression promote cell proliferation, survival, migration, and angiogenesis, making it an important **therapeutic target** in advanced gastric cancer. *Over expression of C-erb* - **Overexpression of C-erbB-2 (HER2/neu)** is found in approximately **10-20% of gastric adenocarcinomas**, particularly the intestinal type. - HER2 amplification or overexpression is a significant **prognostic and predictive biomarker**, and is specifically targeted by **trastuzumab** (Herceptin) therapy in HER2-positive advanced gastric cancer, improving survival outcomes.
Question 2: What is a potential outcome of the integration of a viral genome into a host cell chromosome?
- A. Altered growth
- B. Malignancy
- C. Latency
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - The insertion of a viral genome, known as a **provirus**, into the host chromosome can lead to a variety of sustained and complex interactions. - This integration can cause **long-term changes** in cell behavior, including altered gene expression and cell cycle regulation, which may manifest as any of the specified outcomes. *Malignancy* - Viral integration can interrupt or activate host genes, such as **oncogenes** or **tumor suppressor genes**, leading to uncontrolled cell proliferation and potential tumor formation. - An example is **human papillomavirus (HPV)** integrating into host cells, increasing the risk of cervical cancer. *Altered growth* - Integration can change the cell's normal growth patterns, either by promoting excessive division or by causing cell cycle arrest, impacting tissue development and function. - This can be due to the insertion of viral promoters or enhancers near growth-regulating genes. *Latency* - The integrated viral genome can remain dormant within the host chromosome without producing new viral particles for extended periods, a state known as **latency**. - During latency, the virus can be reactivated later to cause a productive infection, as seen with **herpesviruses**.
Question 3: Sun damage causes malignant transformation of the skin by:
- A. Direct DNA damage
- B. Free radical formation
- C. Induction of pyrimidine dimers (Correct Answer)
- D. Mutation of p53 due to UV exposure
Explanation: ***Induction of pyrimidine dimers*** - **Ultraviolet (UV) radiation** from the sun causes the formation of **covalent bonds between adjacent pyrimidine bases** (thymine or cytosine) on the same DNA strand, creating pyrimidine dimers [1]. - These dimers lead to **DNA distortion**, interfering with DNA replication and transcription, and if not repaired, can result in **mutations** that contribute to carcinogenesis [2]. *Free radical formation* - While UV radiation can induce **reactive oxygen species** (free radicals) that cause DNA damage, the primary mechanism of malignant transformation leading to skin cancer is the direct formation of pyrimidine dimers. - Free radicals cause a variety of oxidative damage to DNA, proteins, and lipids, but **pyrimidine dimers are unique to UV exposure** and are the main initiators of UV-induced skin cancer. *Direct DNA damage* - This option is too broad; while pyrimidine dimer formation is a form of direct DNA damage, it is the **most specific and significant mechanism** of malignant transformation due to sun exposure [3]. - Non-specific direct DNA damage can also occur from other sources, but the hallmark of UV-induced damage is the creation of **photoproducts like pyrimidine dimers**. *Mutation of p53 due to UV exposure* - **p53 gene mutations** are frequently found in skin cancers, particularly **squamous cell carcinoma**, and are indeed induced by UV radiation. - However, the mutation of p53 is a **consequence** of the initial DNA damage (specifically pyrimidine dimers not being repaired), not the primary mechanism by which sun damage *causes* malignant transformation [2]. The induction of pyrimidine dimers *leads* to these mutations. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 322-323. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 332-333. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 220-221.
Question 4: Field carcinogenesis theory is commonly seen in
- A. Head and neck cancer (Correct Answer)
- B. Cervical cancer
- C. Prostate cancer
- D. Breast cancer
Explanation: ***Head and neck cancer*** - **Field carcinogenesis** refers to the concept that a large area of tissue is exposed to carcinogens, leading to multiple primary tumors or recurrences [1]. - In **head and neck squamous cell carcinoma**, extensive exposure of the mucosal lining to tobacco and alcohol promotes widespread genetic alterations [1]. *Cervical cancer* - Primarily linked to **human papillomavirus (HPV) infection**, which causes localized lesions that may progress [2]. - While different areas of the cervix can be affected, the underlying mechanism is more focal infection rather than diffuse field exposure. *Prostate cancer* - Development is often associated with **age**, **genetics**, and **hormonal factors** (androgens). - It typically arises from a single or a few distinct foci within the prostate gland, not pervasive field change [3]. *Breast cancer* - Characterized by distinct lesions originating from ductal or lobular epithelium and influenced by **hormones** and **genetics** [4]. - While multifocal breast cancer can occur, it is generally considered the result of multiple independent events or spread from an initial lesion, not a widespread "field" of precancerous tissue in the same way as head and neck. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 738-739. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 222-223. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 993-994. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1059-1060.
Question 5: Which of the following is not a tumor suppressor gene?
- A. p53
- B. HER2 (Correct Answer)
- C. RB
- D. BRCA1
Explanation: ***HER2*** - **HER2** (**Human Epidermal growth factor Receptor 2**) is an **oncogene**, meaning it promotes cell growth and division when overexpressed [1]. - It is a **receptor tyrosine kinase** that, when activated, signals cells to grow and divide, and its amplification is associated with aggressive forms of breast cancer [1]. *p53* - **p53** is a well-known **tumor suppressor gene** that plays a critical role in cell cycle control and apoptosis. - It detects DNA damage and can halt cell division or initiate programmed cell death to prevent the proliferation of damaged cells. *BRCA1* - **BRCA1** (**BReast CAncer gene 1**) is a **tumor suppressor gene** involved in DNA repair. - Mutations in BRCA1 are strongly associated with increased risk of hereditary breast and ovarian cancers due to compromised DNA damage repair mechanisms. *RB* - The **retinoblastoma protein (RB)** is a classic example of a **tumor suppressor gene**. - It acts as a gatekeeper for cell cycle progression from G1 to S phase, preventing uncontrolled cell division by binding to and inactivating E2F transcription factors. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 291-294.
Question 6: Radiation causes cell death by:
- A. Charring of nucleoproteins
- B. Ionization (Correct Answer)
- C. Disruption of cytosol
- D. Destroying their mitochondria
Explanation: ***Ionization*** - Radiation, particularly **ionizing radiation**, causes cell death by directly or indirectly damaging cellular components through the process of **ionization**. [1] - This involves the removal of electrons from atoms or molecules, leading to the formation of highly reactive **free radicals** (especially hydroxyl radicals from water radiolysis) that can damage DNA, proteins, and lipids. [1] - The most critical lethal lesion is **DNA double-strand breaks**, which are difficult to repair and trigger apoptosis or mitotic catastrophe. [1] *Charring of nucleoproteins* - **Charring** typically refers to the combustion or burning of organic matter, which is not the mechanism of cell death caused by therapeutic radiation doses. - While radiation can cause protein denaturation, it does not lead to the macroscopic charring of nucleoproteins within cells. *Disruption of cytosol* - While severe radiation damage can impact the entire cell, direct and selective **disruption of the cytosol** is not the primary or most impactful mechanism of radiation-induced cell death. - The critical targets for radiation-induced cell death are primarily the **nucleus** and its DNA, not the cytoplasm. [2] *Destroying their mitochondria* - Although radiation can induce **mitochondrial dysfunction** and contribute to cell death through apoptosis, it is not the initial or primary mechanism of cell destruction. - The most critical and direct damage leading to cell death is inflicted upon the **DNA** in the nucleus, particularly causing double-strand breaks. [1] **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-102. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 438-439.
Question 7: Which of the following is not considered an occupational cancer?
- A. Lung
- B. Breast (Correct Answer)
- C. Liver
- D. Bladder
Explanation: ***Breast*** - Breast cancer has a **limited association** with occupational exposure compared to other cancers [1], mainly influenced by genetic and hormonal factors. - While some studies suggest minor correlations, the **impact of environment** and occupation is considerably less significant for breast cancer. *Bladder* - Strongly linked to **aromatic amines** from dyes and rubber manufacturing [2], as well as exposures to **chemical irritants**. - The **occupational risk** is well-documented, particularly among workers in the chemical industry [1]. *Liver* - Associated with **chemical exposures** such as aflatoxins and certain industrial solvents, particularly in the manufacturing and agriculture sectors. - Significant occupational hazards, like **vinyl chloride**, have demonstrated a clear link to liver cancer [2]. *Lung* - Closely tied to **asbestos** [1][3], **smoke**, and other pollutants, highlighting the role of industrial environments in increasing risk. - **Occupational exposure** remains a major contributor to lung cancer rates, particularly in mining and construction [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 286. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 217-218. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 221-222.
Question 8: The strongest occupational risk factor for hematological carcinoma is
- A. Benzene (Correct Answer)
- B. Lithium
- C. Radiation exposure
- D. Cigarette smoke
Explanation: ***Benzene*** - Benzene exposure is recognized as a potent **carcinogen** linked to various hematological malignancies, including **leukemia** [1]. - It affects the **bone marrow**, leading to dysplastic changes and ultimately malignancy. *Nicotine* - Although nicotine is associated with **smoking-related cancers**, it is not directly linked to **hematological carcinomas**. - Its primary role is in causing **lung cancer**, rather than blood cancers. *Lithium* - Lithium is primarily used for **bipolar disorder** and does not have a known link to causing hematological malignancies. - Side effects are more related to **nephrotoxicity** rather than carcinogenic effects. *Alcohol* - Alcohol consumption is primarily associated with **liver cancers** and not specifically linked to hematological carcinomas [2]. - It can contribute to general malignancy development but is not a direct cause of blood cancers. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 286. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 217-218.
Question 9: Which of the following is NOT a recognized cause of Urothelial Carcinomas?
- A. Industrial solvents
- B. Exposure to thorotrast
- C. Alcohol consumption (Correct Answer)
- D. Smoking
Explanation: ***Alcohol consumption*** - Research does not support a direct association between **alcohol consumption** and an increased risk of urothelial carcinomas. - While excessive alcohol can lead to other forms of cancer, it is not a recognized risk factor for **bladder cancer** specifically. *Smoking* - Smoking is a well-established risk factor for **urothelial carcinomas**, significantly increasing the risk of **bladder cancer** [1]. - It is responsible for up to **50% of bladder cancer cases**, due to carcinogens in tobacco smoke [1]. *Exposure to thorotrast* - **Thorotrast**, a radiopaque contrast medium, is associated with **radiation exposure**, which is a known risk for urothelial carcinomas [3]. - Its use has been linked to increased incidence of bladder cancer due to radioactive properties [3]. *Industrial solvents* - Exposure to various **industrial solvents** such as **aromatic amines** has been linked to a higher risk of developing urothelial carcinomas [1][2]. - These chemicals are commonly found in **dyes**, **rubber**, and other manufacturing processes [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 968-970. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 217-218. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 216-217.
Question 10: In which type of lung carcinoma is the p53 mutation most commonly observed?
- A. Adenocarcinoma
- B. Squamous cell carcinoma (SCC) (Correct Answer)
- C. Large cell carcinoma
- D. Small cell carcinoma
Explanation: ***Small cell carcinoma*** - **Small cell lung carcinoma (SCLC)** has the highest frequency of **p53 mutations**, occurring in approximately **90-95%** of cases. - These mutations are associated with the **aggressive nature** and **poor prognosis** of SCLC, contributing to its rapid growth and early metastasis. *Adenocarcinoma* - **Adenocarcinoma** has p53 mutations in approximately **50-60%** of cases, which is less frequent than SCLC. - This subtype is more commonly associated with **EGFR mutations** and **ALK rearrangements**, particularly in non-smokers. *Squamous cell carcinoma (SCC)* - **Squamous cell carcinoma** shows p53 mutations in about **70-80%** of cases, but still lower than SCLC. - It is more strongly associated with **smoking** and often displays mutations in **CDKN2A** and **PIK3CA** pathways. *Large cell carcinoma* - **Large cell carcinoma** has variable p53 mutation rates, typically **40-60%** of cases. - This subtype is less well-characterized molecularly and represents a **diagnosis of exclusion** among lung cancers.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free